Trading volume in Gilead Sciences jumped 260 percent on Friday over its 10-day average, after the biopharmaceutical company reported positive results from an early clinical trial of a recently acquired hepatitis C drug.
Here's a look at other stocks in the S&P 1,500 index that displayed unusual volume in the trading session.